author-photo

Robert S. DiPaola

Rutgers University
University of Kentucky
University of Medicine and Dentistry of New Jersey

321

Papers

13405

Citations

Citation Trend

Filter By

Papers (218) Sort By

Journal Conference Others

Plasma KIM-1 is associated with recurrence risk after nephrectomy for localized renal cell carcinoma: A trial of the ECOG-ACRIN Research Group (E2805).

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805.

2021 BJUI
Show All
- Source
- Cite
- Save
Citations (0)
A phase I, dose-expansion cohort study on the safety of a cannabidiol for biochemical recurrence in prostate cancer patients.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial.

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trial.

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Prevalence of SARS-CoV-2 IgG antibodies in health care workers at a tertiary care academic medical center - An assessment of occupational infection risk.

2021 American Journal of Infection Control
Show All
- Source
- Cite
- Save
Citations (0)
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (4)
Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805).

2020 The Prostate
Show All
- Source
- Cite
- Save
Citations (3)
The impact of the expression of the transcription factor MYBL2 on outcomes of patients with localized and advanced prostate cancer.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of baseline serum IL-8 on metastatic hormone-sensitive (mHSPC) prostate cancer outcomes in the phase III CHAARTED trial (E3805).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)